| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-08 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |